Corresponding Author

Michael Grabe

Cardiovascular Research Institute, Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, USA

Correspondence

Michael Grabe, Cardiovascular Research Institute, Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.

Email: michael.grabe@ucsf.edu

John M. Rosenberg, Department of Biological Sciences, University of Pittsburgh, Pittsburgh, PA, USA.

Email: jmr@pitt.edu

Charles W. Wolgemuth, Departments of Molecular and Cellular Biology and Physics, University of Arizona, Tucson, AZ, USA.

Email: wolg@arizona.edu

Search for more papers by this author